| Financial Year |
March 31 2023 |
| Monetary Funds |
1,970,773,869.36 |
| Held-for-trading Financial Assets |
1,238,702.86 |
| Notes Receivable |
33,580,000.00 |
| Accounts Receivable |
680,611,052.09 |
| Advances to Suppliers |
122,936,353.55 |
| Other Receivables |
11,059,696.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
771,965,091.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
541,297,842.48 |
| Other Current Assets |
14,687,124.74 |
| Total Current Assets |
4,927,352,036.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
27,488,871.17 |
| Investment Properties |
28,396,377.05 |
| Fixed Assetes |
1,222,537,606.04 |
| Under-construction Projects |
586,888,047.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
343,995,652.42 |
| R&D expenses |
471,024,879.88 |
| Goodwill |
56,039,379.24 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
38,131,003.60 |
| Other Non-Current Assets |
111,669,682.19 |
| Sub-Total of Non-Current Assets |
2,886,171,499.25 |
| Total Assets |
7,813,523,536.17 |
| Short-Term Loans |
340,160,950.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,598,857,311.31 |
| Accounts Payable |
1,135,022,898.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
192,369,270.48 |
| Taxes Payable |
8,746,742.21 |
| Interest Payable |
-- |
| Dividend Payable |
496,876,800.00 |
| Other payables |
769,438,659.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
15,845,808.68 |
| Sub-Total of Current Liabilities |
4,182,332,475.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
32,531,664.69 |
| Deferred Income Tax Liabilities |
6,823,212.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
115,819,038.81 |
| Total Liabilities |
4,298,151,514.72 |
| Paid-In Capital(Or Share Stock) |
475,493,100.00 |
| Capital Surplus |
846,977,076.95 |
| Surplus Reserve |
242,230,517.39 |
| LESS:Treasury Stock |
50,299,125.00 |
| Undistributed Profits |
996,448,199.66 |
| Minority Stockholder's Interest |
988,223,747.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,527,148,274.35 |
| Owner's Equity（Stockholder's Equity） |
3,515,372,021.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,813,523,536.17 |
